Clinical Trials Directory

Trials / Completed

CompletedNCT02265367

Novel Medication as a Potential Smoking Cessation Aid

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
25 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to provide preliminary information assessing if levomilnacipran may be effective at increasing smoking cessation rates.

Conditions

Interventions

TypeNameDescription
DRUGLevomilnacipran
DRUGPlacebo

Timeline

Start date
2015-01-01
Primary completion
2017-05-01
Completion
2017-05-01
First posted
2014-10-15
Last updated
2022-04-22
Results posted
2022-04-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02265367. Inclusion in this directory is not an endorsement.

Novel Medication as a Potential Smoking Cessation Aid (NCT02265367) · Clinical Trials Directory